{
    "nctId": "NCT02863146",
    "briefTitle": "Efficacy of the Use of Refrigerant Helmet to Prevent Alopecia in Patients Treated With Eribulin for Breast Cancer",
    "officialTitle": "Efficacy of the Use of a Refrigerant Helmet to Prevent Alopecia in Patients Treated With Eribulin for Locally Advanced or Metastatic Breast Cancer Pretreated With Anthracyclines and Taxanes",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer, Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 23,
    "primaryOutcomeMeasure": "Alopecia grade after 3 cycles of eribulin according to NCI-CTCAE v4.0",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patient who has a locally advanced or metastatic breast cancer\n* Indication of Halaven treatment :\n\npatient pretreated with anthracyclines or taxanes, patient who has received at least 1 chemotherapy regimen for their advanced or metastatic stage\n\n* Patient who has had enough time to have retrieved her hair or whose last chemotherapy regimen didn't induce alopecia.\n* Aged \u2265 18 years\n* Non-opposition of the patient must have been collected\n\nExclusion Criteria:\n\n* Skin metastasis of the scalp\n* Sensitivity to cold, cold agglutinin disease or cryoglobulinemia\n* Impossibility to submit at the study procedures due to geographic, social or mental reasons",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}